Trial intelligence / Profile preview

Dexamethasone for treatment of multiple sclerosis exacerbations

2006-003113-40Phase 4Active

Sponsor
Department of Neurology, University Medical Center Groningen
Start
Jul 2006
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of dexamethasone in multiple sclerosis (MS) and secondary-progressive multiple sclerosis (SPMS) (2 arms), sponsored by Department of Neurology, University Medical Center Groningen. Started Jul 2006; status: active.

02

Drugs

dexamethasone
03

Conditions

multiple sclerosis (MS)secondary-progressive multiple sclerosis (SPMS)

Beyond the preview

Go deeper on 2006-003113-40.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-003113-40.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call